Anavex Life Sciences Corp. (NASDAQ: AVXL)

This lawsuit is for anyone who acquired securities in Anavex Life Sciences Corp. (NASDAQ: AVXL) from November 26, 2025 through August 28, 2026.

The lawsuit alleges that the Company and certain of its executives violated federal law. Specifically, the lawsuit alleges that, throughout the time period mentioned above, the Company misled investors regarding its financial condition. More specifically, the lawsuit alleges that the Company misled investors by telling investors that the Company had sufficient internal controls when the Company lacked sufficient internal controls.

On May 11, 2026, the Company filed with the SEC a notification of late filing which disclosed it had “terminated the employment of Dr. Christopher Missling as the Chief Executive Officer of the Company on April 30, 2026 for, among other things, conduct that the Special Committee believed was inconsistent with Company Policy.” On this news, the price of the Company’s stock dropped precipitously on unusually heavy trading volume. Then, on August 28, 2026, Anavex filed an Amended 2025 Annual Report with the SEC. The report stated, in part, that as a result of a review by the Special Committee, management, in consultation with the Audit Committee of the Board, “concluded that there was a material weakness in internal control over financial reporting that existed at September 30, 2025” and that “the Company’s disclosure controls and procedures were not effective.” On this news, the price of the Company’s stock again dropped precipitously on unusually heavy trading volume.

The Law Offices of Howard G. Smith seeks to recover damages on behalf of class members. If you acquired securities in BAnavex Life Sciences Corp. (NASDAQ: AVXL) from November 26, 2025 through August 28, 2026 you may join the lawsuit by submitting your information online, or you may call the Law Offices of Howard G. Smith and speak to Mr. Smith directly to learn how he can protect your rights.